Institutul de Pneumoftiziologie "Marius Nasta"
In research, Institutul de Pneumoftiziologie "Marius Nasta" stands highest in Medicine (#14,543 of 17,978 worldwide), Health Sciences (#17,171 of 20,462 worldwide) and Pulmonary and Respiratory Medicine (#2,680 of 2,717 worldwide), over all time. Relative to its size it is most specialised in Medicine — Medicine is 4.2× its share of world research.
- World rank, 2022–2025
- #22,330 of 28,054 · #35,998 all time
- Rank in Romania
- #99 of 126
- Research works
- 679 ▼ 5% vs 2013–17
- Citations
- 1.3k 1.9 per fractional work
- Top-10% rate
- 13.0% record average 16.5%
- Open access
- 24% world 28%
What is Institutul de Pneumoftiziologie "Marius Nasta" known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #14,543 of 17,978 | 1.9% | 563 | |
| Health SciencesDomain | #17,171 of 20,462 | 1.8% | 603 | |
| Pulmonary and Respiratory MedicineSubfield | #2,680 of 2,717 | 0.8% | 181 |
Each strip is that field’s whole ranked pool, with the notch where Institutul de Pneumoftiziologie "Marius Nasta" sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institutul de Pneumoftiziologie "Marius Nasta" specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.2× the share of its output that it takes of world research.
- MedicineField · 54.3 works4.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
- Medicine 4.2×
- Immunology and Microbiology 1.6×
- Decision Sciences 1.0×
- Neuroscience 0.8×
- Psychology 0.8×
- Biochemistry, Genetics and Molecular Biology 0.7×
- Energy 0.5×
- Environmental Science 0.5×
- Health Professions 0.5×
- Business, Management and Accounting 0.4×
- Nursing 0.3×
- Chemistry 0.2×
- Mathematics 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.0×
- Pharmacology, Toxicology and Pharmaceutics 0.0×
- Social Sciences 0.0×
Who are the top researchers at Institutul de Pneumoftiziologie "Marius Nasta"?
Ranked on the composite score, Ciprian Bolca, S Duţu and C Didilescu lead among researchers whose main affiliation is Institutul de Pneumoftiziologie "Marius Nasta".
- 1 Ciprian Bolca Romania · #155,154 worldwide 108 citations · 23 works
- 2 S Duţu Romania · #616,987 worldwide 4 citations · 26 works
- 3 C Didilescu Romania · #635,150 worldwide 8 citations · 38 works
- 4 Radu Stoica Romania · #819,297 worldwide 14 citations · 19 works
- 5 Ioana Munteanu Romania · #896,806 worldwide 6 citations · 15 works
- 6 Florin Mihălţan Romania · #960,545 worldwide 10 citations · 22 works
- 7 Florin Mihălţan Romania · #1,079,115 worldwide 39 citations · 64 works
- 8 P Mihăilescu Romania · #1,080,197 worldwide 0 citations · 17 works
- 9 P Galbenu Romania · #1,172,772 worldwide 0 citations · 19 works
- 10 Ioan Cordoş Romania · #1,183,919 worldwide 16 citations · 16 works
Which keywords describe research at Institutul de Pneumoftiziologie "Marius Nasta"?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Immune Response, Management, Vaccine, Drug Resistance and Antiretroviral Therapy.
- Therapy
- ACE2 Receptor
- Immunocompromised Patients
- Tumor Staging
- CT Screening
- Adjuvant Therapy
- SARS-CoV-2
- COPD
- Respiratory
- Clinical Practice Guidelines
- Global Burden
- Myofibroblast
- TGF-ß
- Chemotherapy
- Fibrosis
- Tuberculosis
- Antiretroviral Therapy
- Vaccine
- Immune Response
- Diagnosis
- Epidemiology
- Treatment
- Management
- Drug Resistance
- Mycobacterium tuberculosis
- Cardiovascular Disease
- Inflammation
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
- Pandemic
- Mortality
- Meta-Analysis
- Radiotherapy
- spirometry
- Surgical Management
- Lung Cancer
- HIV Infection
- HIV
- Infertility
- Cognitive Impairment
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology15▲ 5.7×43 topics
- Diagnosis12▲ 18×17 topics
- Treatment8▲ 10×13 topics
- Immune Response6▲ 15×8 topics
- Management5▲ 10.0×13 topics
- Vaccine5▲ 19×9 topics
- Drug Resistance4▲ 21×3 topics
- Antiretroviral Therapy4▲ 33×6 topics
- Mycobacterium tuberculosis4▲ 95×1 topic
- Tuberculosis4▲ 100×1 topic
- Cardiovascular Disease3▲ 4.5×12 topics
- Fibrosis3▲ 27×5 topics
- Inflammation3▲ 2.2×17 topics
- Chemotherapy3▲ 6.2×9 topics
- Interstitial Lung Disease3▲ 67×2 topics
- TGF-ß3▲ 28×3 topics
- Idiopathic Pulmonary Fibrosis3▲ 90×1 topic
- Myofibroblast3▲ 90×1 topic
- Pandemic3▲ 3.9×6 topics
- Global Burden3▲ 7.6×6 topics
- Mortality3▲ 7.0×6 topics
- Clinical Practice Guidelines3▲ 7.2×7 topics
- Meta-Analysis3▲ 6.5×5 topics
- Respiratory2▲ 38×2 topics
- Radiotherapy2▲ 8.6×3 topics
- COPD2▲ 47×1 topic
- spirometry2▲ 47×1 topic
- SARS-CoV-22▲ 9.1×4 topics
- Surgical Management2▲ 7.3×6 topics
- Adjuvant Therapy2▲ 22×2 topics
- Lung Cancer2▲ 16×2 topics
- CT Screening2▲ 40×1 topic
- HIV Infection2▲ 26×3 topics
- Tumor Staging2▲ 24×1 topic
- HIV2▲ 30×3 topics
- Immunocompromised Patients2▲ 43×2 topics
- Infertility2▲ 18×2 topics
- ACE2 Receptor2▲ 10×2 topics
- Cognitive Impairment2▲ 9.2×2 topics
- Therapy2▲ 12×3 topics
Which research topics does Institutul de Pneumoftiziologie "Marius Nasta" publish most on?
By volume in 2022–2025: Tuberculosis Research and Epidemiology, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research and Lung Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Tuberculosis Research and Epidemiology Infectious Diseases 4 works
- 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 3 works
- 3 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 5 Diagnosis and treatment of tuberculosis Surgery 1 works
- 6 Infectious Diseases and Tuberculosis Surgery 1 works
- 7 Sarcoidosis and Beryllium Toxicity Research Physiology 1 works
- 8 Air Quality and Health Impacts Health, Toxicology and Mutagenesis 1 works
- 9 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 10 Mycobacterium research and diagnosis Epidemiology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institutul de Pneumoftiziologie "Marius Nasta"'s research output changed?
Output in 2018–2022 was 5% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bucharest
- Universitatea Națională de Știință și Tehnologie Politehnica București
- University of Bucharest
- Bucharest University of Economic Studies
- Romanian Academy
- Carol Davila University of Medicine and Pharmacy
- Clinical Emergency Hospital Bucharest
- Academia Oamenilor de Știință din România
- University of Agronomic Sciences and Veterinary Medicine of Bucharest
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.